Sponsor:
City of Hope Medical Center
Code:
NCT06022965
Conditions
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Best Practice
Comprehensive Geriatric Assessment
Electronic Health Record Review
Questionnaire Administration
Supportive Care
Brief summary:
Conditions
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06022965
Start date
Jul 24, 2023
Status verified date
Oct, 2025
Completion date
Jan 24, 2027
Anticipated
Primary completion date
Jan 24, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Enrollment
216 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: ARM I (GAIN-S)
active comparator: ARM II (SOC)
Interventions
Best Practice
Comprehensive Geriatric Assessment
Electronic Health Record Review
Questionnaire Administration
Supportive Care
Telemedicine
Primary outcome measure
Locations
City of Hope Medical Center
Recruiting
Duarte, California, United States, 91010
Contacts
Principal Investigator:
William Dale
City of Hope Antelope Valley
Recruiting
Lancaster, California, United States, 93534
Contacts
Principal Investigator:
William Dale
City of Hope Upland
Recruiting
Upland, California, United States, 91786
Contacts
Principal Investigator:
William Dale
Sponsor
City of Hope Medical Center
Last update posted
Oct 6, 2025
Last verified
Oct, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by City of Hope Medical Center on 2025-10-06.